GeneTex

  • Country / Location Selection

United States (US)

EBAG9 blocking peptide

Cat. No. GTX89290-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX89290.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-KEAQRLMKKEQN

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Estrogen Receptor Binding Site Associated, Antigen, 9 , Eb9 , Pdaf , Ebag9

Background

This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for this gene. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for EBAG9 blocking peptide (GTX89290-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for EBAG9 blocking peptide (GTX89290-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239